Health service utilization, substance use treatment response, and death in patients with opioid use disorder and comorbid hepatitis C findings from prospective cohort study with administrative database linkage
Brittany B. Dennis(McMaster University), Zainab Samaan(Queen's University), Samantha Young(British Columbia Centre on Substance Use), Glenda Babe(McMaster University), Jeffrey H. Samet(Boston Medical Center), Victoria Weaver(British Royal University), Anastasia Gayowsky(McMaster University), Tea Rosic(Children's Hospital of Eastern Ontario), Aijaz Ahmed(Stanford University), Claire de Oliveira(Centre for Addiction and Mental Health), Joanna C. Dionne(Impact), Donghee Kim(Chungnam National University), Paxton Bach(University of British Columbia), Lehana Thabane(St. Joseph’s Healthcare Hamilton), Myanca Rodrigues(McMaster University)
Cited by 4
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Nonobese Fatty Liver Disease
|Clinical Gastroenterology and Hepatology|2016|346
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes
|The Canadian Journal of Psychiatry|2024|329
Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine
|Intensive Care Medicine|2020|279
Characterization of Environmental Sources of the Human and Animal Pathogen <i>Cryptococcus gattii</i> in British Columbia, Canada, and the Pacific Northwest of the United States
|Applied and Environmental Microbiology|2006|238